We are live on ! Find out more
FC

FORA Capital Portfolio holdings

AUM $1.36B
1-Year Est. Return 56.1%
This Fund
S&P 500
This Quarter Est. Return
+22.25%
1 Year Est. Return
+56.1%
3 Year Est. Return
+119.91%
5 Year Est. Return
+163.37%
10 Year Est. Return
AUM
$901M
AUM Growth
-$85.4M
Cap. Flow
-$176M
Cap. Flow %
-19.57%
Top 10 Hldgs %
17.52%
Holding
749
New
265
Increased
99
Reduced
113
Closed
272

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$15.8M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$14.4M
3
GE icon
GE Aerospace
GE
+$13.8M
4
NFLX icon
Netflix
NFLX
+$13.7M
5
NVDA icon
NVIDIA
NVDA
+$12.8M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$17.4M
2
CSCO icon
Cisco
CSCO
+$17.3M
3
MRVL icon
Marvell Technology
MRVL
+$15.3M
4
CVX icon
Chevron
CVX
+$14.7M
5
WMT icon
Walmart Inc
WMT
+$14.3M

Sector Composition

Rank Sector Weight
1 Technology 29.98%
2 Industrials 17.54%
3 Consumer Discretionary 12.37%
4 Financials 9.62%
5 Healthcare 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLD icon
176
Prologis
PLD
$138B
$1.35M 0.15%
+12,825
New +$1.35M
GIS icon
177
General Mills
GIS
$19.2B
$1.31M 0.15%
25,276
-28,776
-53% -$1.59M
DVA icon
178
DaVita
DVA
$15.1B
$1.31M 0.15%
+9,180
New +$1.3M
VRNA
179
DELISTED
Verona Pharma
VRNA
$1.3M 0.14%
13,732
+8,625
+169% +$639K
AFL icon
180
Aflac
AFL
$63.9B
$1.29M 0.14%
12,201
-4,863
-28% -$511K
EQR icon
181
Equity Residential
EQR
$25.4B
$1.28M 0.14%
18,999
+11,773
+163% +$809K
UTHR icon
182
United Therapeutics
UTHR
$26.3B
$1.28M 0.14%
4,462
-5,227
-54% -$1.56M
ZTS icon
183
Zoetis
ZTS
$31.6B
$1.27M 0.14%
8,170
-320
-4% -$50.7K
CWAN
184
DELISTED
Clearwater Analytics
CWAN
$1.27M 0.14%
+58,022
New +$1.33M
RY icon
185
Royal Bank of Canada
RY
$291B
$1.27M 0.14%
9,656
-9,209
-49% -$1.13M
MIR icon
186
Mirion Technologies
MIR
$4.05B
$1.27M 0.14%
+58,903
New +$1.02M
TYL icon
187
Tyler Technologies
TYL
$12.2B
$1.26M 0.14%
2,132
+1,522
+250% +$862K
FFIV icon
188
F5
FFIV
$22.1B
$1.24M 0.14%
4,201
-9,301
-69% -$2.57M
PPG icon
189
PPG Industries
PPG
$25.9B
$1.22M 0.14%
10,749
-6,907
-39% -$747K
WST icon
190
West Pharmaceutical
WST
$23.1B
$1.21M 0.13%
+5,520
New +$1.18M
IBN icon
191
ICICI Bank
IBN
$106B
$1.2M 0.13%
+35,781
New +$1.18M
MLI icon
192
Mueller Industries
MLI
$14.1B
$1.2M 0.13%
30,244
+16,324
+117% +$616K
WSM icon
193
Williams-Sonoma
WSM
$26.7B
$1.18M 0.13%
7,208
-11,405
-61% -$1.79M
FTNT icon
194
Fortinet
FTNT
$112B
$1.18M 0.13%
11,118
-10,592
-49% -$1.07M
BR icon
195
Broadridge
BR
$17.2B
$1.17M 0.13%
+4,832
New +$1.15M
CRI icon
196
Carter's
CRI
$1.43B
$1.17M 0.13%
38,936
+21,378
+122% +$724K
SCCO icon
197
Southern Copper
SCCO
$141B
$1.16M 0.13%
11,892
+8,024
+207% +$706K
LIF
198
Life360
LIF
$3.96B
$1.14M 0.13%
+17,545
New +$902K
EMN icon
199
Eastman Chemical
EMN
$7.8B
$1.14M 0.13%
+15,243
New +$1.2M
FRT icon
200
Federal Realty Investment Trust
FRT
$10.9B
$1.13M 0.13%
11,892
+5,103
+75% +$482K

Similar funds

FORA Capital's Q2 2025 Portfolio in Review

As of Q2 2025, FORA Capital held 749 positions worth $901M, down 8.7% from $986M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

FORA Capital withdrew a net $176M in Q2 2025, closing 272 positions and reducing 113 holdings. Its most notable exit was Oracle, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, FORA Capital opened a new position in Apple worth $16M.

  • FORA Capital's largest Q2 2025 buy was Apple: 78,207 shares worth $16M.
  • FORA Capital added most to Berkshire Hathaway Class B in Q2 2025, an estimated $14.4M increase.
  • FORA Capital's biggest Q2 2025 reduction was Microsoft, cutting an estimated $12.8M.
  • FORA Capital fully exited Oracle in Q2 2025, selling an estimated $17.4M.
  • FORA Capital's ten largest holdings make up 18% of its $901M portfolio in Q2 2025.
  • FORA Capital opened 265 new positions and closed 272 in Q2 2025.
  • FORA Capital's portfolio value fell 8.7% quarter-over-quarter to $901M.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.